2:50 – 3:10 pm Friday, September 4

Paper Presentation: Symptom Reporting Strategies—Perceived Usefulness and User Satisfaction of Electronic and Paper-and-Pencil Symptom Tracking Diaries for Young Children with Cancer: Parent Perspectives (231-2)

"Because much of the cancer care for young children occurs in the outpatient setting, parents have the responsibility of identifying and responding to the child’s symptoms at home. Having a tool that parents could use to record their child's daily symptoms could help to provide insight into the symptoms the child is experiencing. Although multiple resources have been developed to support symptom tracking, ensuring usability is key.

Read more...
Speaker:
Sharifa Al-Qaaydeh, PhD RN
CNE Hours
0.33
2:30 – 3:30 pm Friday, September 4

Below the Surface:  Applying Evidence-Based Practice in Skin Care Management with the Hematopoietic Cell Transplant Patient (229)

Children and adolescents undergoing hematopoietic cell transplant (HCT) are at high risk for developing skin complications. Nurses play a vital role in the assessment, prevention, and management of skin issues in this population where multiple factors lead to skin complications.

Read more...
Speaker:

Nancy Noonan, MS RN PCNS-BC BMTCN®

Linda Abramovitz, MSN RN CNS FAAN BMTCN®

Lisa Pinner, RN MSN CNS BMTCN® CPON® 

CNE Hours
1
12:15 – 1:15 pm Friday, September 4

High Risk Neuroblastoma in the new decade: Incorporating targeted therapies to maximize impact in current Children’s Oncology Group trials (C226)

coglogoWhile the overall cure rate for childhood cancer is approaching 80%, the prognosis for long-term survival for children with high risk neuroblastoma lags considerably behind, at 50%–60%. Upfront standard treatment for high-risk neuroblastoma protocols within the Children’s Oncology Group (COG) has historically utilized all available modalities of cancer treatment including chemotherapy, surgery, myeloablative chemotherapy with stem cell rescue, radiation therapy, differentiating agents, and most recently biologic therapy with anti-GD2 antibody (dinutuximab) used post consolidation in ANBL0032.

Read more...
Speaker:

Wendy Fitzgerald, MSN APRN PPCNP-BC

Denise Mills, MN RN(EC) NP CPHON®

CNE Hours
1
12:35 – 12:55 pm Friday, September 4

Paper Presentation: Outcomes of Serious Illness on Nurses, Patients, and Families—Inpatient Deaths of Children with Cancer: DNAR and CPR Events in Children Who Don’t Survive to Hospital Discharge (225-2)

Death in children with malignancy may result from refractory disease or acute complications during therapy. In this population, little is known about the medical interventions received in the last week of life from the overall cohort of children who die from cancer or related complications as inpatients. Perceptions of under- or over-treatment can cause distress among families and staff, yet the prevalence of do not attempt resuscitation (DNAR) orders, use of CPR, and other supportive therapies remains poorly described.

Read more...
Speaker:

Liza-Marie Johnson, MD MPH MSB HEC-C

Belinda Mandrell, PhD RN CPNP

CNE Hours
0.33
12:15 – 1:15 pm Friday, September 4

Protect Your Professional Life: Beware of Predatory Publishers and Conferences (223)

Can you spot a “fake” journal or conference? The publishers of predatory journals are motivated by self-interests which are primarily financial.1 They are characterized by: a) false or misleading information; b) deviation from best editorial and publication practices: c) a lack of transparency, and/or d) the use of aggressive and indiscriminate solicitation practices.”

Read more...
Speaker:

Mary Hooke, PhD APRN PCNS FAAN CPON®

Kristin Stegenga, PhD RN

Suzanne Ameringer, PhD RN FAAN

CNE Hours
1
2:30 – 3:30 pm Thursday, September 3

Reproductive Health: from Diagnosis through Survivorship – Resources and Perspectives from the Children’s Oncology Group (C221)

coglogoPuberty and sexual and reproductive health are normal parts of human growth and development. Adolescence and young adulthood are developmental times of exploration of sexual identity and planning for the future, which may include parenting goals. A cancer diagnosis does not preclude a patient or their family from concern about sexual and reproductive health.

Read more...
Speaker:
Brooke Cherven, PhD MPH RN CPON®
Barbara Lockart, DNP APRN PC & AC CPHON®
CNE Hours
1
12:55 – 1:15 pm Thursday, September 3

Paper Presentation: Supporting Patient Well-Being and Quality of Life—Psychosocial interventions to improve social health of adolescents and young adults with cancer: A review (214-3)

The incidence of cancer diagnosis in the adolescent and young adult (AYA) population has been increasing, and more frequently these patients are being cared for at pediatric institutions. The AYA population has a set of psychosocial needs that differ from other age groups. Failure to tend to these needs leads to a host of negative health outcomes from cancer and therapy and negatively impacts the quality of life.

Read more...
Speaker:
Clifton Thornton, MSN RN CNMT CPNP
CNE Hours
0.34
12:15 – 1:15 pm Thursday, September 3

Caring for Pediatric Patients with Malignant Bone Tumors: The Advanced Practice Nurse’s Perspective (213)

Children, adolescents, and young adults with malignant bone tumors require expert and specialized care beginning at diagnosis and continuing throughout therapy and beyond. Each patient’s treatment plan is likely to include systemic chemotherapy plus radiation and/or surgery to achieve local tumor control.

Read more...
Speaker:
Kristen Dalton, MSN RN CPNP-AC CPHON®
Elizabeth Cummings, MSN RN CPNP-AC CPHON®
Amy Rapino, MSN CRNP
CNE Hours
1
Subscribe to this RSS feed